Developing Potent and Selective Anticancer Therapy through Chemical Approaches and the Combination of Cationic Amphipathic Oncolytic Peptides.

Bui Thi Phuong, Hai et al.·Journal of medicinal chemistry·2025·
RPEP-102442025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Developing Potent and Selective Anticancer Therapy through Chemical Approaches and the Combination of Cationic Amphipathic Oncolytic Peptides.
Published In:
Journal of medicinal chemistry, 68(11), 11875-11893 (2025)
Database ID:
RPEP-10244

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-10244·https://rethinkpeptides.com/research/RPEP-10244

APA

Bui Thi Phuong, Hai; Nguyen, Bao Loc; Huang, Linyu; Nguyen, Thi Oanh Oanh; Le, Ngoc Duy; Kim, Beomsu; Patil, Basavaraj Rudragouda; Nguyen Quoc, Thang; Kim, Jeonghwan; Luong, Huy Xuan; Kim, And Jong Oh. (2025). Developing Potent and Selective Anticancer Therapy through Chemical Approaches and the Combination of Cationic Amphipathic Oncolytic Peptides.. Journal of medicinal chemistry, 68(11), 11875-11893. https://doi.org/10.1021/acs.jmedchem.5c00699

MLA

Bui Thi Phuong, Hai, et al. "Developing Potent and Selective Anticancer Therapy through Chemical Approaches and the Combination of Cationic Amphipathic Oncolytic Peptides.." Journal of medicinal chemistry, 2025. https://doi.org/10.1021/acs.jmedchem.5c00699

RethinkPeptides

RethinkPeptides Research Database. "Developing Potent and Selective Anticancer Therapy through C..." RPEP-10244. Retrieved from https://rethinkpeptides.com/research/bui-2025-developing-potent-and-selective

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.